Two-Wave Nanotherapy to Target the Stroma and Optimize Gemcitabine Delivery to a Human Pancreatic Cancer Model in Mice

ACS Nano - United States
doi 10.1021/nn404083m
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

The Next Wave of Stroma-Targeting Therapy in Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2019English

P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2006English

Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine

Oncology Letters
Cancer ResearchOncology
2019English

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research
Cancer ResearchOncology
2004English

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Cancer Research
Cancer ResearchOncology
2008English

A Step Towards a New Targeted Nanotherapy for Pancreatic Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy